Statements (50)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:disease
|
gptkbp:caused_by |
gptkb:virus
|
gptkbp:community_health |
yes
|
gptkbp:community_impact |
millions affected annually
|
gptkbp:complication |
organ failure
hemorrhagic manifestations shock syndrome |
gptkbp:death |
varies by region
higher in children |
gptkbp:defense |
gptkb:international_collaboration
public awareness campaigns research funding surveillance programs guidelines for management |
gptkbp:diagnosis |
blood test
Dengue warning signs |
gptkbp:difficulty_levels |
can be life-threatening
|
gptkbp:epidemiology |
seasonal outbreaks
|
gptkbp:first_described_by |
1950s
|
gptkbp:geographic_distribution |
tropical and subtropical regions
|
https://www.w3.org/2000/01/rdf-schema#label |
Dengue hemorrhagic fever
|
gptkbp:incubation_period |
4 to 10 days
|
gptkbp:is_vulnerable_to |
gptkb:Qdenga
gptkb:Dengvaxia |
gptkbp:prevention |
vaccination
mosquito control |
gptkbp:research_focus |
treatment protocols
vaccine development vector control strategies |
gptkbp:risk_factor |
age
weakened immune system previous dengue infection |
gptkbp:scientific_classification |
Category A
|
gptkbp:symptoms |
nausea
vomiting skin rash high fever joint and muscle pain pain behind the eyes severe headache bleeding tendencies |
gptkbp:transmission |
Aedes mosquito bites
|
gptkbp:treatment |
supportive care
pain relievers fluid replacement avoid aspirin |
gptkbp:vector |
gptkb:Aedes_aegypti
gptkb:Aedes_albopictus |
gptkbp:bfsParent |
gptkb:Dengue_fever
|
gptkbp:bfsLayer |
6
|